Latest Breaking News On - Nova receives - Page 1 : vimarsana.com

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Kazuko matsudaGeoff obrienExchange commissionMedicinova incJapan patent officeNova receivesNew patent coveringMacular injuryStandard marketTokyo stock exchangeCode numberChief medical officerOptical coherence tomographyPrivate securities litigation reform act

MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe

MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Geoff obrienKazuko matsudaMedicinova incTrademark officeExchange commissionEuropean patent officeNova receivesNew patent coveringStandard marketTokyo stock exchangeCode numberChief medical officerPrivate securities litigation reform act

MediciNova Receives a Notice of Allowance for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Canada

MediciNova Receives a Notice of Allowance for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Canada
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Geoff obrienKazuko matsudaCanadian intellectual property officeExchange commissionEuropean commissionMedicinova incNova receivesNew patent coveringAmyotrophic lateral sclerosisStandard marketTokyo stock exchangeCode numberChief medical officerOrphan medicinal product designationPrivate securities litigation reform act

MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Europe

MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Europe
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Geoff obrienKazuko matsudaMedicinova incEuropean patent officeExchange commissionTrademark officeNova receivesNew patent coveringMacular injuryStandard marketTokyo stock exchangeCode numberChief medical officerOptical coherence tomographyPrivate securities litigation reform act

MediciNova Receives a New Patent Covering MN-001 for the Treatment of Scleroderma and Systemic Sclerosis in Europe

MediciNova Receives a New Patent Covering MN-001 for the Treatment of Scleroderma and Systemic Sclerosis in Europe
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Geoff obrienKazuko matsudaJuntendo universityCanadian intellectual property officeExchange commissionMedicinova incEuropean patent officeNova receivesNew patent coveringSystemic sclerosisStandard marketTokyo stock exchangeCode numberChief medical officerCollagen typeFast track